أبوت تعلن فصل 1900 موظف

أعلنت شركة أبوت اليوم نيتها لفصل 1900 موظف أغلبهم في أمريكا و ذلك في خطوه لاعادة تكوين الشركة . المتحدثه باسم الشركه ميليسا بورتز أكدت الخبر و قالت ان العدد يمثل 2 في المائه من قوة الشركه في العالم.

Abbott reported Wednesday that it will eliminate 1900 positions, mostly in the US, as part of a restructuring of its US pharmaceutical business. Spokeswoman Melissa Brotz confirmed that the cuts, which represent 2 percent of its global workforce, are in addition to the 3000 job losses announced last September following Abbott’s $6.2-billion acquisition of Solvay’s drug unit.

The company indicated that the latest cuts were being made “in response to changes in the healthcare industry, including US Healthcare Reform and the challenging regulatory environment,” and in an effort to “streamline commercial and manufacturing operations, improve efficiencies and reduce costs.” Abbott said the staff reductions would lead to charges of approximately $295 million in the coming years to transfer product manufacturing to new locations, with $165 million projected to be recorded this year.

Abbott announced the news alongside its fourth-quarter results, which saw the company’s profit for the period fall 6.4 percent to $1.4 billion.